Chanre Veena Rheumatology And Immunology Center Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 19-07-2024
- Paid Up Capital ₹ 1.17 M
as on 19-07-2024
- Company Age 5 Months 5 Days
About Chanre Veena Rheumatology And Immunology Center
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.17 M, as per Ministry of Corporate Affairs (MCA) records.
Srikantiah Chandrashekara and Veena Ramachandran serve as directors at the Company.
- CIN/LLPIN
U86100KA2024PTC190929
- Company No.
190929
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chanre Veena Rheumatology And Immunology Center?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srikantiah Chandrashekara  | Director | 17-Jul-2024 | Current |
| Veena Ramachandran | Director | 17-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Chanre Veena Rheumatology And Immunology Center.
Enhance accessibility to Chanre Veena Rheumatology And Immunology Center's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chanre Veena Rheumatology And Immunology Center?
Unlock access to Chanre Veena Rheumatology And Immunology Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chanre Rheumatology And Immunology Center And Research Private LimitedActive 17 years 9 monthsSrikantiah Chandrashekara is a mutual person
Chanre Health Care And Research Private LimitedActive 19 years 27 daysSrikantiah Chandrashekara is a mutual person
- Chanre Diagnostic Services Private LimitedActive 9 years 7 months
Srikantiah Chandrashekara is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chanre Veena Rheumatology And Immunology Center?
Unlock and access historical data on people associated with Chanre Veena Rheumatology And Immunology Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chanre Veena Rheumatology And Immunology Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chanre Veena Rheumatology And Immunology Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.